Justia Antitrust & Trade Regulation Opinion Summaries

After the FTC voted to hold POM and the associated parties liable for violating the Federal Trade Commission Act (FTC Act), 15 U.S.C. 45(a)(1) and 52(a), and ordered them to cease and desist from making misleading and inadequately supported claims about the health benefits of POM products, POM petitioned for review. The court denied most of petitioners' challenges; the court saw no basis to set aside the Commission's conclusion that many of POM's ads made misleading or false claims about POM products; and the Commission had no obligation to adhere to notice-and-comment rulemaking procedures. Further, the court held that the Commission's order is valid to the extent it requires disease claims to be substantiated by at least one randomized and controlled human clinical trial (RCT); the order fails Central Hudson scrutiny because it categorically requires two RCTs for all disease-related claims; the Commission has failed to adequately justify an across-the-board two-RCT requirement for all disease claims by petitioners; and, therefore, Part I of the Commission's order will be modified to require petitioners to possess at least one RCT. The court denied the petition for review in all other respects. View "POM Wonderful LLC v. FTC" on Justia Law

Felder's filed an antitrust suit against All Star and GM, alleging that GM's "Bump the Competition" program, which lowers the consumer price for GM-manufactured parts below the prices of equivalent "generic" auto parts manufactured by others, is an unlawful predatory pricing scheme. GM lowers the price by providing rebates to dealers like All Star that sell GM-manufactured parts for the reduced prices. The court concluded that the effect of this rebate in deciding whether Felder's can meet one of the essential elements of a predatory pricing claim - that defendant is selling its products at a price below average variable cost - should be considered. Accordingly, the court affirmed the district court's dismissal of the antitrust claims based on Felder's failure to adequately define the relevant geographic market and its earlier finding that Felder's did not allege below-cost pricing. View "Felder's Collision Parts v. All Star Advertising" on Justia Law

AstraZeneca, which sells a heartburn drug called Nexium, and three generic drug companies (“generic defendants”) that sought to market generic forms of Nexium, entered into settlement agreements in which the generic defendants agreed not to challenge the validity of the Nexium patents and to delay the launch of their generic products. Certain union health and welfare funds that reimburse plan members for prescription drugs (the named plaintiffs) alleged that the settlement agreements constituted unlawful agreements between Nexium and the generic defendants not to compete. Plaintiffs sought class certification for a class of third-party payors, such as the named plaintiffs, and individual consumers. The district court certified a class. Relevant to this appeal, the class included individual consumers who would have continued to purchase branded Nexium for the same price after generic entry. The First Circuit affirmed the class certification, holding (1) class certification is permissible even if the class includes a de minimis number of uninjured parties; (2) the number of uninjured class members in this case was not significant enough to justify denial of certification; and (3) only injured class members will recover. View "In re Nexium Antitrust Litig." on Justia Law

Plaintiffs filed suit against AQHA, alleging violations of the Sherman Act, 15 U.S.C. 1, 2, and Texas antitrust law. Plaintiffs' allegations stemmed from votes by the Stud Book and Registration Committee of the AQHA, which had blocked AQHA registration of horses created through somatic cell nuclear transfer (SCNT or cloning). On appeal, AQHA challenged the district court's denial of its motion for judgment as a matter of law (JMOL). The court concluded that reasonable jurors could not draw any inference of conspiracy from the evidence presented, because it neither tends to exclude the possibility of independent action nor does it suggest the existence of any conspiracy at all. Therefore, the court concluded that the JMOL motion should have been granted in the absence of substantial evidence on the issue of an illegal conspiracy to restrain trade under Section 1 of the Act. Further, the Section 2 claim failed as a matter of law because AQHA is not a competitor in the allegedly relevant market for elite Quarter Horses. Accordingly, the court reversed and rendered judgment for AQHA. View "Abraham & Veneklasen Joint Venture v. American Quarter Horse Assoc." on Justia Law

This case arose when the Oakland Athletics wanted to move to the City of San Jose, but the City falls within the exclusive operating territory of the San Francisco Giants. The City, seeking approval of the move, filed suit against MLB, alleging violations of state and federal antitrust laws, of California's consumer protection statute, and of California tort law. The district court granted MLB's motion to dismiss on all but the tort claims and the City appealed. The City argues that the baseball industry's historic exemption from the antitrust laws does not apply to antitrust claims relating to franchise relocation. The court held, however, that antitrust claims against MLB's franchise relocation policies are precluded by Flood v. Kuhn, and, under Portland Baseball Club, Inc. v Kuhn, the court rejected any antitrust claim that was wholly unrelated to the reserve clause. Therefore, the City's claims under the Sherman Act and Clayton Act, 15 U.S.C. 1-7 and 15 U.S.C. 12-27, must be dismissed. Further, the City's antitrust claims necessarily fall with its federal claims where the City can point to no case that has ever held that state antitrust claims continue to be viable after federal antitrust claims have been dismissed under the baseball exemption. An independent claim under California's unfair competition law is also barred so long as MLB's activities are lawful under the antitrust laws. Accordingly, the court affirmed the judgment of the district court. View "City of San Jose v. Comm'r of Baseball" on Justia Law

When Appellant, a resident of the Pondview Condominiums, did not pay his condominium fees on time, the condominium trustees hired law firm Marcus, Errico, Emmer and Brooks, P.C. (“MEEB”) to collect Appellant’s debt. MEEB filed nine collection actions in Massachusetts state court against Appellant and prevailed in two of them. Displeased with MEEB’s collection activities, Appellant sued MEEB in federal district court, alleging violations of federal and state law. The magistrate judge concluded that MEEB committed numerous violations of the Fair Debt Collection Practices Act (FDCPA) and that the FDCPA violations constituted “per se” violations of Mass. Gen. Laws ch. 93A. Upon reconsideration, the magistrate judge reversed in part, finding MEEB not liable under Chapter 93A. The First Circuit reversed the magistrate judge’s determination that MEEB was not liable under Chapter 93A, holding that MEEB’s violations of the FDCPA constituted per se Chapter 93A violations by virtue of the unambiguous statutory language in the FDCPA and the Federal Trade Commission Act. View "McDermott v. Marcus, Errico, Emmer & Brooks" on Justia Law

Orca Communications Unlimited, LLC filed this action against Ann Noder, its former president, and the competing company Noder started after she left Orca, asserting common law tort clams based on alleged misappropriation of confidential information. The superior court dismissed the complaint, concluding that Orca’s common law claims were preempted by Arizona’s Uniform Trade Secrets Act (AUTSA), which creates an exclusive cause of action - and displaces conflicting causes of action - for claims based on the misappropriation of trade secrets. The Supreme Court reversed, holding (1) AUTSA does not displace common-law claims based on alleged misappropriation of confidential information that is not a trade secret; and (2) therefore, AUTSA did not displace Orca’s unfair competition claim. View "Orca Commc’ns Unlimited, LLC v. Noder" on Justia Law

Class representatives sued Kentucky real estate firms, alleging violation of Section 1 of the Sherman Antitrust Act, 15 U.S.C. 1, by participating in a horizontal conspiracy to fix commissions charged in Kentucky real estate transactions at an anti-competitive rate. The certified class consists of people who sold residential real estate in Kentucky from 2001 to 2005, and used the services of defendants. Several defendants settled. The district court entered summary judgment for remaining defendants, excluding the opinions of plaintiffs’ experts with respect to whether collusion among the defendants was the likely economic explanation of the pricing of commissions. The Sixth Circuit affirmed, stating that although the plaintiffs produced a good deal of circumstantial evidence that would support a theory of collusion, the conduct at issue was also consistent with permissible competition. View "Hyland v. HomeServices of America, Inc." on Justia Law

Dragon Systems, Inc. (Dragon), a voice recognition software company that faced a deteriorating financial situation, hired Goldman Sachs (Goldman) to provide financial advice and assistance in connection with a possible merger. In 2000, Lernout & Hauspie Speech Products N.V. (Lernout & Hauspie) acquired Dragon. When it was discovered that Lernout & Hauspie had fraudulently overstated its earnings, the merged company filed for bankruptcy, and the Dragon name and technology were sold from the estate. Plaintiffs, two groups of Dragon shareholders, filed suit against Goldman, alleging negligent and intentional misrepresentation, negligence, gross negligence, breach of fiduciary duty, and violations of Mass. Gen. Laws ch. 93A. A jury found in favor of Goldman on Plaintiffs’ common law claims, and district court found that Goldman had not violated chapter 93A. The First Circuit affirmed, holding (1) the district court correctly articulated the legal standard applicable to Plaintiffs’ chapter 93A claims and correctly applied that standard to its factual findings; and (2) Plaintiffs’ arguments that they were entitled to a new trial on their common law claims because of evidentiary errors and erroneous jury instructions were without merit. View "Baker v. Goldman, Sachs & Co." on Justia Law

Dick McClary submitted an application for health insurance to Golden Rule Insurance Company that failed to disclose proposed insured Patti Denney’s preexisting condition. Golden Rule issued a policy covering Denney, but later denied coverage for a proposed surgery based on the fact that the conditions documented in Denney’s medical records were not disclosed in her insurance application. The Kansas Insurance Department imposed sanctions on Golden Rule for unfair claim settlement practices, concluding that Golden Rule had wrongfully denied Denney coverage for a medically necessary procedure. The district court affirmed. The court of appeals reversed, concluding that McClary was not acting as Golden Rule’s soliciting agent when he submitted Denney’s health insurance application. The Supreme Court (1) reversed the court of appeals’ decision on the agency question, as substantial evidence supported the conclusion that McClary had the actual authority to solicit and submit applications directly to Golden Rule; and (2) reversed the Department and the district court on their ruling that Golden Rule violated Kan. Stat. Ann. 40-2404(9)(f) but affirmed the finding of a violation of subsection (d); and (3) affirmed the Department’s remedy. View "Golden Rule Ins. Co. v. Tomlinson" on Justia Law